0001437749-24-019350.txt : 20240605 0001437749-24-019350.hdr.sgml : 20240605 20240605171212 ACCESSION NUMBER: 0001437749-24-019350 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TATE JEFFREY CENTRAL INDEX KEY: 0001499075 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39780 FILM NUMBER: 241022951 MAIL ADDRESS: STREET 1: C/O CTD HOLDINGS, INC. STREET 2: 27317 NW 78TH AVENUE CITY: HIGH SPRINGS STATE: FL ZIP: 32643 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc. CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 593029743 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6714 NW 16TH STREET, SUITE B CITY: GAINESVILLE STATE: FL ZIP: 32653 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: PO BOX 1180 CITY: ALACHUA STATE: FL ZIP: 32616-1180 FORMER COMPANY: FORMER CONFORMED NAME: CTD HOLDINGS INC DATE OF NAME CHANGE: 20000913 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 4 1 rdgdoc.xml FORM 4 X0508 4 2024-06-03 0000922247 Cyclo Therapeutics, Inc. CYTH 0001499075 TATE JEFFREY C/O CYCLO THERAPEUTICS, INC. 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32163 1 1 Chief Operating Officer 0 Stock Option (Right to Buy) 1.28 2024-06-03 4 A 0 110732 0 A 2034-06-03 Common Stock 110732 110732 D The option vests over a one year period in equal quarterly installments. /s/ Jeffrey Tate 2024-06-05